Eigen

Eigen Health is a California-founded medical technology company (established 1975) specializing in advanced MRI-ultrasound fusion systems and minimally invasive focal therapies for prostate cancer diagnosis and treatment. The company operates in 36+ countries, serving academic institutions, hospitals, and clinical practices globally. The Artemis platform is their flagship 3D semi-robotic prostate biopsy system featuring real-time organ tracking and prospective needle navigation with switchable transrectal and transperineal modules. It performs rigid and elastic registration of multimodal imaging (MRI, PET-CT, PSMA PET-MRI) to real-time ultrasound. The TPO (Transperineal Operative) module is purpose-built for transperineal approaches with integrated ultrasound capabilities. ProFuse CAD is their advanced radiology software for computer-assisted detection, real-time mpMRI analysis, and MRI data preparation for fusion guidance. The Cryo product combines MRI/ultrasound fusion-guided biopsy with cryoablation for minimally invasive, often outpatient prostate cancer treatment. The company reports supporting clinical outcomes for over 3,000,000 patients worldwide and maintains multiple patents in fusion imaging and needle guidance technology. ISO 13485 certified, indicating compliance with medical device quality management standards. The company emphasizes long-term partnerships with distributors and clinical institutions for seamless technology integration into practice and research.